They assessed the effects of an ActRIIB decoy receptor in several mouse models of cancer cachexia, including a murine colon-26 carcinoma and two xenograft models: human G361 melanoma and human TOV-21G ovarian carcinoma. The gene discussed is ACVR2B; the disease is cancer.